GlassScriptPhysician profile
Beth M Zanaglio
NPI 1982903472
$908.68
in general payments reported to CMS, 2019-2025
6 companies · $516 in 2025
The $516 reported for 2025 was more than what 75% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $232 · 2024: $161 · 2025: $516.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $909.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $908.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avita Medical Americas, LLC | $621.81 | 2024-2025 | Recell, Cohealyx, Permeaderm |
| Smith+Nephew, INC. | $156.85 | 2023-2024 | Oasis, Acticoat 4" X 4", Collagenase Santyl |
| Catalyst Pharmaceuticals, INC. | $50.40 | 2023 | Fycompa |
| Acera Surgical, INC. | $39.60 | 2023 | Restrata Wound Matrix |
| Solventum Corporation | $20.86 | 2024 | Prevena, V.A.C.Instill, 3m Cavilon |
| Polynovo North America LLC | $19.16 | 2024 | Novosorb Btm |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Beth Zanaglio listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.